Interactions between B-Lymphocytes and Type 1 NKT Cells in Autoimmune Diabetes

By Dufour Francois   Baxter Alan   Silveira Pablo  

Journal of Immunotoxicology, Vol. 5, Iss. 2, 2008-04 ,pp. : 249-257

Informa Healthcare

Access to resources Recommend Favorite

Effects of Various Environmental Stress Paradigms and Adrenalectomy on the Expression of Autoimmune Type 1 Diabetes in the Non-obese Diabetic (NOD) Mouse

By Durant S.   Coulaud J.   Amrani A.   El Hasnaoui A.   Dardenne M.   Homo-Delarche F.  

Journal of Autoimmunity, Vol. 6, Iss. 6, 1993-12 ,pp. : 735-751

Academic Press

Access to resources Recommend Favorite

Anti-4-1BB-based immunotherapy for autoimmune diabetes: lessons from a transgenic non-obese diabetic (NOD) model

By Sytwu H.-K.   Lin W.-D.   Roffler S.R.   Hung J.-T.   Sung H.-S.   Wang C.-H.   Cheng T.-L.   Tsou S.-C.   Hsi S.-C.   Shen K.-L.  

Journal of Autoimmunity, Vol. 21, Iss. 3, 2003-11 ,pp. : 247-254

Elsevier

Access to resources Recommend Favorite

Tumor Necrosis Factor Mediates the Protective Effect of Freund's Adjuvant against Autoimmune Diabetes in BB Rats

By Rabinovitch A.   Suarez-Pinzon W.L.   Lapchak P.H.   Meager A.   Power R.F.  

Journal of Autoimmunity, Vol. 8, Iss. 3, 1995-03 ,pp. : 357-366

Academic Press

Access to resources Recommend Favorite

The immunosuppressant LF 15-0195 prevents experimental autoimmune myasthenia gravis in Brown-Norway rats

By Duplan V.   Dutartre P.   Druet P.   Saoudi A.  

Transplantation Proceedings, Vol. 34, Iss. 7, 2002-11 ,pp. : 2962-2965

Elsevier

Access to resources Recommend Favorite